Emmes launches Advantage eClinical as a standalone cloud native clinical technology platform
Rockville, Emmes – a global, full-service Contract Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announces that it will introduce to market its third generation version of Advantage eClinical at Society for Clinical Trials (SCT) in San Diego, May 15th – 18th. The cloud platform of Advantage eClinical will be available as a standalone software product after undergoing more than two years of development. The system has been specifically designed to provide fast study builds, greater flexibility, and insights to clinical trial sponsors of all sizes. Advantage eClinical provides a fully integrated suite of data management applications backed by decades of domain expertise. The
The post Emmes launches Advantage eClinical as a standalone cloud native clinical technology platform appeared first on Pharma Mirror Magazine.